Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Shanghai Pharmaceuticals Holding Co Ltd
OTC:SHPMY
Shanghai Pharmaceuticals Holding Co Ltd
OTC:SHPMY
Price:
7.078
USD
10.42%
Market Closed
Market Cap:
$6.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
OTC:SHPMY
|
CN |
|
Steel Dynamics Inc
NASDAQ:STLD
|
US |
|
B
|
Barclays PLC
XETRA:BCY
|
UK |
|
B
|
Bristol-Myers Squibb Co
DUS:BRM
|
US |
|
Everbright Securities Co Ltd
SSE:601788
|
CN |
|
Hermes International SCA
XETRA:HMI
|
FR |
Wall St Price Targets
SHPMY Price Forecast
Based on 8 analysts
Based on 8 analysts
+43% Upside
from
$7.078
today
Shanghai Pharmaceuticals Holding Co Ltd (SHPMY)’s 12-month stock price forecast through October 2027 has a consensus target of $10.148, implying 43% upside. The forecast is based on price targets from 8 Wall Street analysts.
SHPMY Analyst Rating
No ratings yet
No ratings yet
Shanghai Pharmaceuticals Holding Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SHPMY's stock price target?
Price Target
10.148
USD
10.148
USD
According to Wall Street analysts, the average 1-year price target for SHPMY is 10.148 USD with a low forecast of 5.377 USD and a high forecast of 11.858 USD.
What is the Revenue forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
12%
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 12%.
What is the Pre-Tax Income forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is 4%.
What is the Net Income forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 5%.